仟源医药
(300254)
| 流通市值：20.45亿 | | | 总市值：22.57亿 |
| 流通股本：2.25亿 | | | 总股本：2.48亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 181,736,278.48 | 846,606,161.05 | 608,815,610.55 | 401,112,573 |
| 营业收入 | 181,736,278.48 | 846,606,161.05 | 608,815,610.55 | 401,112,573 |
| 二、营业总成本 | 173,536,336.36 | 792,256,406.11 | 563,187,725.7 | 374,472,295.53 |
| 营业成本 | 55,412,915.77 | 280,157,407.4 | 200,975,472.43 | 133,676,032.49 |
| 税金及附加 | 2,337,838.82 | 11,363,900.38 | 7,602,907.74 | 4,453,237.58 |
| 销售费用 | 69,071,111.47 | 302,495,118.14 | 220,249,038.85 | 145,171,548.8 |
| 管理费用 | 27,967,449.67 | 125,912,367.67 | 86,429,230.97 | 54,999,331.22 |
| 研发费用 | 12,891,525.28 | 56,533,374.23 | 36,311,001.29 | 28,549,365.43 |
| 财务费用 | 5,855,495.35 | 15,794,238.29 | 11,620,074.42 | 7,622,780.01 |
| 其中:利息费用 | 5,945,558.65 | 16,976,345.71 | 12,338,642.78 | 8,168,167.17 |
| 其中:利息收入 | 115,875.22 | 1,316,030 | 833,309.79 | 635,175.48 |
| 加:投资收益 | 27,498.3 | 4,544,279.82 | 3,861,750.62 | -29,333.12 |
| 资产处置收益 | 7,881,410.52 | 7,507,360.71 | 7,406,904.13 | 7,423,884.9 |
| 资产减值损失(新) | 43,124.34 | -7,318,590.89 | -1,946,560.62 | 179,276.52 |
| 信用减值损失(新) | -80,477.88 | -5,818,941.95 | -2,496,772.31 | -940,634.76 |
| 其他收益 | 1,315,409.03 | 11,730,203.72 | 9,250,279.31 | 8,076,840.01 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 17,386,906.43 | 64,994,066.35 | 61,703,485.98 | 41,350,311.02 |
| 加:营业外收入 | 6,099,294.69 | 22,206,003.55 | 12,775,457.35 | 9,769,995.45 |
| 减:营业外支出 | 1,235,939.12 | 6,557,442.19 | 1,071,602.25 | 488,407.03 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 22,250,262 | 80,642,627.71 | 73,407,341.08 | 50,631,899.44 |
| 减:所得税费用 | 3,054,506.51 | 5,883,079.45 | 6,248,808.45 | 1,546,497.51 |
| 六、净利润 | 19,195,755.49 | 74,759,548.26 | 67,158,532.63 | 49,085,401.93 |
| 持续经营净利润 | 19,195,755.49 | 74,759,548.26 | 67,158,532.63 | 49,085,401.93 |
| 归属于母公司股东的净利润 | 10,390,380.78 | 42,190,119.18 | 44,153,255.59 | 33,502,484.5 |
| 少数股东损益 | 8,805,374.71 | 32,569,429.08 | 23,005,277.04 | 15,582,917.43 |
| (一)基本每股收益 | 0.04 | 0.17 | 0.18 | 0.14 |
| (二)稀释每股收益 | 0.04 | 0.17 | 0.18 | 0.14 |
| 九、综合收益总额 | 19,195,755.49 | 74,759,548.26 | 67,158,532.63 | 49,085,401.93 |
| 归属于母公司股东的综合收益总额 | 10,390,380.78 | 42,190,119.18 | 44,153,255.59 | 33,502,484.5 |
| 归属于少数股东的综合收益总额 | 8,805,374.71 | 32,569,429.08 | 23,005,277.04 | 15,582,917.43 |
| 公告日期 | 2025-04-19 | 2025-04-15 | 2024-10-24 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |